In this episode, Scott Becker breaks down five key market stories, including a rough day for stocks, private equity fund struggles, and surprising comebacks from companies like CVS and Intel.

In this episode, Gregory P. Hawver, Partner at McGuireWoods LLP, discusses the growing role of independent sponsors in the deal-making world. He breaks down how independent sponsors differ from traditional private equity funds, their unique deal structures, and why this investment model is gaining traction. Plus, he shares insights on the upcoming McGuireWoods Independent Sponsor Conference – October 14-15, 2025.

In this episode, Scott Becker shares a personal progress report across business, investments, fitness, tennis, and golf.

In this episode, Scott Becker explores the reality of achieving success in multiple ventures.

In this episode, Scott Becker discusses the $1.2 billion in federal funding lost by Johns Hopkins and Columbia.

In this episode, Scott Becker covers five key stories, including the top five companies by market cap, standout stocks from Friday’s trading, struggling retail stocks, and more.

In this episode, Scott Becker discusses the UK’s slowing economy, the EU’s response to Trump’s trade policies, and key stock market movers—including Palantir, Peloton, and Tempus AI.

In this episode, Matt Wolf, Healthcare Senior Analyst at RSM, breaks down the latest market trends, including declining equity values, IPO delays, and the increasing reliance on private capital.

In this episode, Scott Becker covers three key market stories, including Oscar Health and RH stock drops, before discussing his updated Elon Musk scorecard.

In this episode, Scott Becker discusses the results of a Twitter poll on government spending, where 78% of respondents favored reductions. He also gives special shoutouts to standout business leaders and investment funds making an impact.